NEW YORK (GenomeWeb) – The University of Florida and Kings College London have received a $3.7 million grant to study the immune repertoire profiles of type 1 diabetes.
The researchers will collaborate with Adaptive Biotechnologies to sequence immune repertoire profiles using its ImmunoSeq assay. Researchers from the University of Oslo will also collaborate on bioinformatics and machine learning.